Global Ayurveda Market

Ayurveda Comprehensive Study by Application (Gastrointestinal Diseases, Cardiac Disorders, Respiratory Disorders, Psychological Disorders, Movement Disorders, Others), Treatment (Vamana, Virechana, Nasyam, Vasthy), Form (Herbal, Herbomineral, Mineral), Distribution Channel (Online Channel, Offline Channel), End-user (Ayurveda Centres, Hospitals, Clinics, Others) Players and Region - Global Market Outlook to 2030

Ayurveda Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 15.02%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Ayurveda
Ayurveda is the oldest healing science originated in India more than 5,000 years ago. It emphasizes good health and prevention and treatment of illness through lifestyle practices such as massage, meditation, yoga, and dietary changes and the use of herbal remedies. According to this, the five elements of nature (Space, Air, Fire, Water and Earth) combine in the body as three components known as Vatta, Pitta, and Kapha. Ayurveda works on balancing these doshas to be required for optimal health. It can be used to maintain health, reduce stress, and improve flexibility, strength, and stamina. The Indian Government set up AYUSH ministry to promote Ayurveda and traditional systems of medicine while the indian council of medical research is conducting molecular-based studies to validate the efficacy of Ayurveda medicines

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR15.02%


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain competitive advantage through combined collaborations. Analyst at AMA Research estimates that Global Players will contribute the maximum growth to Global Ayurveda market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Emami Group (India), Vicco Laboratories Pvt. Ltd. (India), Patanjali Ayurved Ltd. (India), Baidyanath Group (India), Dabur (India), Hamdard (Wakf) Laboratories (India), Charak Pharma (India), Zandu Pharmaceutical Works Ltd. (India), Elzac Herbals (India) and The Himalaya Drug Company (India) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Ayurveda market by , Application (Gastrointestinal Diseases, Cardiac Disorders, Respiratory Disorders, Psychological Disorders, Movement Disorders and Others) and Region.



On the basis of geography, the market of Ayurveda has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Vamana will boost the Ayurveda market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Form, the sub-segment i.e. Herbal will boost the Ayurveda market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Online Channel will boost the Ayurveda market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-user, the sub-segment i.e. Ayurveda Centres will boost the Ayurveda market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Shifting of Consumers toward Ayurvedic Treatment and Increasing Focus of Consumers on Preventive Healthcare

Market Growth Drivers:
Increasing Acceptance of Ayurveda Treatment Worldwide, Effective Treatment without Any Side Effects of the Medicines, Increased Investment of Large Players in the Market and RIse in the Promotional Activities by Manufacturers of Ayurvedic Products

Challenges:
Less Awareness in Western Countries and Lack of Availability of the Skilled Professionals

Restraints:
Lack of Scientific Validation for Ayurveda Treatments and Availability of Alternative Treatments in the Market

Opportunities:
Growing Ayurveda Industry Worldwide, Rise in the E-commerce Industry and Increasing Online Demand for Ayurvedic Products

Market Leaders and their expansionary development strategies
In November 2023, Unilever has collaborated with the Department of Ayurveda, this strategic partnership with the Department of Ayurveda highlights Lever Ayush's commitment to promoting traditional medicine and integrating traditional medical knowledge into modern health and beauty concepts.
In January 2024, SMART 2.0 launched for Ayurveda teaching professionals. This program to promote robust clinical studies in priority areas of Ayurveda with Ayurveda academic institutions/hospitals across the country through mutual collaboration.


Key Target Audience
Ayurveda Product Manufacturers, Research Professionals, Emerging Companies, Raw Material Suppliers/ Buyers, Distributors, Government Body & Associations and End-user

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Gastrointestinal Diseases
  • Cardiac Disorders
  • Respiratory Disorders
  • Psychological Disorders
  • Movement Disorders
  • Others
By Treatment
  • Vamana
  • Virechana
  • Nasyam
  • Vasthy

By Form
  • Herbal
  • Herbomineral
  • Mineral

By Distribution Channel
  • Online Channel
  • Offline Channel

By End-user
  • Ayurveda Centres
  • Hospitals
  • Clinics
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Acceptance of Ayurveda Treatment Worldwide
      • 3.2.2. Effective Treatment without Any Side Effects of the Medicines
      • 3.2.3. Increased Investment of Large Players in the Market
      • 3.2.4. RIse in the Promotional Activities by Manufacturers of Ayurvedic Products
    • 3.3. Market Challenges
      • 3.3.1. Less Awareness in Western Countries
      • 3.3.2. Lack of Availability of the Skilled Professionals
    • 3.4. Market Trends
      • 3.4.1. Shifting of Consumers toward Ayurvedic Treatment
      • 3.4.2. Increasing Focus of Consumers on Preventive Healthcare
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Ayurveda, by Application, Treatment, Form, Distribution Channel, End-user and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Ayurveda (Value)
      • 5.2.1. Global Ayurveda by: Application (Value)
        • 5.2.1.1. Gastrointestinal Diseases
        • 5.2.1.2. Cardiac Disorders
        • 5.2.1.3. Respiratory Disorders
        • 5.2.1.4. Psychological Disorders
        • 5.2.1.5. Movement Disorders
        • 5.2.1.6. Others
      • 5.2.2. Global Ayurveda by: Treatment (Value)
        • 5.2.2.1. Vamana
        • 5.2.2.2. Virechana
        • 5.2.2.3. Nasyam
        • 5.2.2.4. Vasthy
      • 5.2.3. Global Ayurveda by: Form (Value)
        • 5.2.3.1. Herbal
        • 5.2.3.2. Herbomineral
        • 5.2.3.3. Mineral
      • 5.2.4. Global Ayurveda by: Distribution Channel (Value)
        • 5.2.4.1. Online Channel
        • 5.2.4.2. Offline Channel
      • 5.2.5. Global Ayurveda by: End-user (Value)
        • 5.2.5.1. Ayurveda Centres
        • 5.2.5.2. Hospitals
        • 5.2.5.3. Clinics
        • 5.2.5.4. Others
      • 5.2.6. Global Ayurveda Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Ayurveda: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Emami Group (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Vicco Laboratories Pvt. Ltd. (India)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Patanjali Ayurved Ltd. (India)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Baidyanath Group (India)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Dabur (India)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Hamdard (Wakf) Laboratories (India)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Charak Pharma (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Zandu Pharmaceutical Works Ltd. (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Elzac Herbals (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. The Himalaya Drug Company (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Ayurveda Sale, by Application, Treatment, Form, Distribution Channel, End-user and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Ayurveda (Value)
      • 7.2.1. Global Ayurveda by: Application (Value)
        • 7.2.1.1. Gastrointestinal Diseases
        • 7.2.1.2. Cardiac Disorders
        • 7.2.1.3. Respiratory Disorders
        • 7.2.1.4. Psychological Disorders
        • 7.2.1.5. Movement Disorders
        • 7.2.1.6. Others
      • 7.2.2. Global Ayurveda by: Treatment (Value)
        • 7.2.2.1. Vamana
        • 7.2.2.2. Virechana
        • 7.2.2.3. Nasyam
        • 7.2.2.4. Vasthy
      • 7.2.3. Global Ayurveda by: Form (Value)
        • 7.2.3.1. Herbal
        • 7.2.3.2. Herbomineral
        • 7.2.3.3. Mineral
      • 7.2.4. Global Ayurveda by: Distribution Channel (Value)
        • 7.2.4.1. Online Channel
        • 7.2.4.2. Offline Channel
      • 7.2.5. Global Ayurveda by: End-user (Value)
        • 7.2.5.1. Ayurveda Centres
        • 7.2.5.2. Hospitals
        • 7.2.5.3. Clinics
        • 7.2.5.4. Others
      • 7.2.6. Global Ayurveda Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Ayurveda: by Application(USD Million)
  • Table 2. Ayurveda Gastrointestinal Diseases , by Region USD Million (2018-2023)
  • Table 3. Ayurveda Cardiac Disorders , by Region USD Million (2018-2023)
  • Table 4. Ayurveda Respiratory Disorders , by Region USD Million (2018-2023)
  • Table 5. Ayurveda Psychological Disorders , by Region USD Million (2018-2023)
  • Table 6. Ayurveda Movement Disorders , by Region USD Million (2018-2023)
  • Table 7. Ayurveda Others , by Region USD Million (2018-2023)
  • Table 8. Ayurveda: by Treatment(USD Million)
  • Table 9. Ayurveda Vamana , by Region USD Million (2018-2023)
  • Table 10. Ayurveda Virechana , by Region USD Million (2018-2023)
  • Table 11. Ayurveda Nasyam , by Region USD Million (2018-2023)
  • Table 12. Ayurveda Vasthy , by Region USD Million (2018-2023)
  • Table 13. Ayurveda: by Form(USD Million)
  • Table 14. Ayurveda Herbal , by Region USD Million (2018-2023)
  • Table 15. Ayurveda Herbomineral , by Region USD Million (2018-2023)
  • Table 16. Ayurveda Mineral , by Region USD Million (2018-2023)
  • Table 17. Ayurveda: by Distribution Channel(USD Million)
  • Table 18. Ayurveda Online Channel , by Region USD Million (2018-2023)
  • Table 19. Ayurveda Offline Channel , by Region USD Million (2018-2023)
  • Table 20. Ayurveda: by End-user(USD Million)
  • Table 21. Ayurveda Ayurveda Centres , by Region USD Million (2018-2023)
  • Table 22. Ayurveda Hospitals , by Region USD Million (2018-2023)
  • Table 23. Ayurveda Clinics , by Region USD Million (2018-2023)
  • Table 24. Ayurveda Others , by Region USD Million (2018-2023)
  • Table 25. South America Ayurveda, by Country USD Million (2018-2023)
  • Table 26. South America Ayurveda, by Application USD Million (2018-2023)
  • Table 27. South America Ayurveda, by Treatment USD Million (2018-2023)
  • Table 28. South America Ayurveda, by Form USD Million (2018-2023)
  • Table 29. South America Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 30. South America Ayurveda, by End-user USD Million (2018-2023)
  • Table 31. Brazil Ayurveda, by Application USD Million (2018-2023)
  • Table 32. Brazil Ayurveda, by Treatment USD Million (2018-2023)
  • Table 33. Brazil Ayurveda, by Form USD Million (2018-2023)
  • Table 34. Brazil Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 35. Brazil Ayurveda, by End-user USD Million (2018-2023)
  • Table 36. Argentina Ayurveda, by Application USD Million (2018-2023)
  • Table 37. Argentina Ayurveda, by Treatment USD Million (2018-2023)
  • Table 38. Argentina Ayurveda, by Form USD Million (2018-2023)
  • Table 39. Argentina Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 40. Argentina Ayurveda, by End-user USD Million (2018-2023)
  • Table 41. Rest of South America Ayurveda, by Application USD Million (2018-2023)
  • Table 42. Rest of South America Ayurveda, by Treatment USD Million (2018-2023)
  • Table 43. Rest of South America Ayurveda, by Form USD Million (2018-2023)
  • Table 44. Rest of South America Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 45. Rest of South America Ayurveda, by End-user USD Million (2018-2023)
  • Table 46. Asia Pacific Ayurveda, by Country USD Million (2018-2023)
  • Table 47. Asia Pacific Ayurveda, by Application USD Million (2018-2023)
  • Table 48. Asia Pacific Ayurveda, by Treatment USD Million (2018-2023)
  • Table 49. Asia Pacific Ayurveda, by Form USD Million (2018-2023)
  • Table 50. Asia Pacific Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 51. Asia Pacific Ayurveda, by End-user USD Million (2018-2023)
  • Table 52. China Ayurveda, by Application USD Million (2018-2023)
  • Table 53. China Ayurveda, by Treatment USD Million (2018-2023)
  • Table 54. China Ayurveda, by Form USD Million (2018-2023)
  • Table 55. China Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 56. China Ayurveda, by End-user USD Million (2018-2023)
  • Table 57. Japan Ayurveda, by Application USD Million (2018-2023)
  • Table 58. Japan Ayurveda, by Treatment USD Million (2018-2023)
  • Table 59. Japan Ayurveda, by Form USD Million (2018-2023)
  • Table 60. Japan Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 61. Japan Ayurveda, by End-user USD Million (2018-2023)
  • Table 62. India Ayurveda, by Application USD Million (2018-2023)
  • Table 63. India Ayurveda, by Treatment USD Million (2018-2023)
  • Table 64. India Ayurveda, by Form USD Million (2018-2023)
  • Table 65. India Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 66. India Ayurveda, by End-user USD Million (2018-2023)
  • Table 67. South Korea Ayurveda, by Application USD Million (2018-2023)
  • Table 68. South Korea Ayurveda, by Treatment USD Million (2018-2023)
  • Table 69. South Korea Ayurveda, by Form USD Million (2018-2023)
  • Table 70. South Korea Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 71. South Korea Ayurveda, by End-user USD Million (2018-2023)
  • Table 72. Taiwan Ayurveda, by Application USD Million (2018-2023)
  • Table 73. Taiwan Ayurveda, by Treatment USD Million (2018-2023)
  • Table 74. Taiwan Ayurveda, by Form USD Million (2018-2023)
  • Table 75. Taiwan Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 76. Taiwan Ayurveda, by End-user USD Million (2018-2023)
  • Table 77. Australia Ayurveda, by Application USD Million (2018-2023)
  • Table 78. Australia Ayurveda, by Treatment USD Million (2018-2023)
  • Table 79. Australia Ayurveda, by Form USD Million (2018-2023)
  • Table 80. Australia Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 81. Australia Ayurveda, by End-user USD Million (2018-2023)
  • Table 82. Rest of Asia-Pacific Ayurveda, by Application USD Million (2018-2023)
  • Table 83. Rest of Asia-Pacific Ayurveda, by Treatment USD Million (2018-2023)
  • Table 84. Rest of Asia-Pacific Ayurveda, by Form USD Million (2018-2023)
  • Table 85. Rest of Asia-Pacific Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 86. Rest of Asia-Pacific Ayurveda, by End-user USD Million (2018-2023)
  • Table 87. Europe Ayurveda, by Country USD Million (2018-2023)
  • Table 88. Europe Ayurveda, by Application USD Million (2018-2023)
  • Table 89. Europe Ayurveda, by Treatment USD Million (2018-2023)
  • Table 90. Europe Ayurveda, by Form USD Million (2018-2023)
  • Table 91. Europe Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 92. Europe Ayurveda, by End-user USD Million (2018-2023)
  • Table 93. Germany Ayurveda, by Application USD Million (2018-2023)
  • Table 94. Germany Ayurveda, by Treatment USD Million (2018-2023)
  • Table 95. Germany Ayurveda, by Form USD Million (2018-2023)
  • Table 96. Germany Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 97. Germany Ayurveda, by End-user USD Million (2018-2023)
  • Table 98. France Ayurveda, by Application USD Million (2018-2023)
  • Table 99. France Ayurveda, by Treatment USD Million (2018-2023)
  • Table 100. France Ayurveda, by Form USD Million (2018-2023)
  • Table 101. France Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 102. France Ayurveda, by End-user USD Million (2018-2023)
  • Table 103. Italy Ayurveda, by Application USD Million (2018-2023)
  • Table 104. Italy Ayurveda, by Treatment USD Million (2018-2023)
  • Table 105. Italy Ayurveda, by Form USD Million (2018-2023)
  • Table 106. Italy Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 107. Italy Ayurveda, by End-user USD Million (2018-2023)
  • Table 108. United Kingdom Ayurveda, by Application USD Million (2018-2023)
  • Table 109. United Kingdom Ayurveda, by Treatment USD Million (2018-2023)
  • Table 110. United Kingdom Ayurveda, by Form USD Million (2018-2023)
  • Table 111. United Kingdom Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 112. United Kingdom Ayurveda, by End-user USD Million (2018-2023)
  • Table 113. Netherlands Ayurveda, by Application USD Million (2018-2023)
  • Table 114. Netherlands Ayurveda, by Treatment USD Million (2018-2023)
  • Table 115. Netherlands Ayurveda, by Form USD Million (2018-2023)
  • Table 116. Netherlands Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 117. Netherlands Ayurveda, by End-user USD Million (2018-2023)
  • Table 118. Rest of Europe Ayurveda, by Application USD Million (2018-2023)
  • Table 119. Rest of Europe Ayurveda, by Treatment USD Million (2018-2023)
  • Table 120. Rest of Europe Ayurveda, by Form USD Million (2018-2023)
  • Table 121. Rest of Europe Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 122. Rest of Europe Ayurveda, by End-user USD Million (2018-2023)
  • Table 123. MEA Ayurveda, by Country USD Million (2018-2023)
  • Table 124. MEA Ayurveda, by Application USD Million (2018-2023)
  • Table 125. MEA Ayurveda, by Treatment USD Million (2018-2023)
  • Table 126. MEA Ayurveda, by Form USD Million (2018-2023)
  • Table 127. MEA Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 128. MEA Ayurveda, by End-user USD Million (2018-2023)
  • Table 129. Middle East Ayurveda, by Application USD Million (2018-2023)
  • Table 130. Middle East Ayurveda, by Treatment USD Million (2018-2023)
  • Table 131. Middle East Ayurveda, by Form USD Million (2018-2023)
  • Table 132. Middle East Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 133. Middle East Ayurveda, by End-user USD Million (2018-2023)
  • Table 134. Africa Ayurveda, by Application USD Million (2018-2023)
  • Table 135. Africa Ayurveda, by Treatment USD Million (2018-2023)
  • Table 136. Africa Ayurveda, by Form USD Million (2018-2023)
  • Table 137. Africa Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 138. Africa Ayurveda, by End-user USD Million (2018-2023)
  • Table 139. North America Ayurveda, by Country USD Million (2018-2023)
  • Table 140. North America Ayurveda, by Application USD Million (2018-2023)
  • Table 141. North America Ayurveda, by Treatment USD Million (2018-2023)
  • Table 142. North America Ayurveda, by Form USD Million (2018-2023)
  • Table 143. North America Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 144. North America Ayurveda, by End-user USD Million (2018-2023)
  • Table 145. United States Ayurveda, by Application USD Million (2018-2023)
  • Table 146. United States Ayurveda, by Treatment USD Million (2018-2023)
  • Table 147. United States Ayurveda, by Form USD Million (2018-2023)
  • Table 148. United States Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 149. United States Ayurveda, by End-user USD Million (2018-2023)
  • Table 150. Canada Ayurveda, by Application USD Million (2018-2023)
  • Table 151. Canada Ayurveda, by Treatment USD Million (2018-2023)
  • Table 152. Canada Ayurveda, by Form USD Million (2018-2023)
  • Table 153. Canada Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 154. Canada Ayurveda, by End-user USD Million (2018-2023)
  • Table 155. Mexico Ayurveda, by Application USD Million (2018-2023)
  • Table 156. Mexico Ayurveda, by Treatment USD Million (2018-2023)
  • Table 157. Mexico Ayurveda, by Form USD Million (2018-2023)
  • Table 158. Mexico Ayurveda, by Distribution Channel USD Million (2018-2023)
  • Table 159. Mexico Ayurveda, by End-user USD Million (2018-2023)
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Company Basic Information, Sales Area and Its Competitors
  • Table 169. Company Basic Information, Sales Area and Its Competitors
  • Table 170. Ayurveda: by Application(USD Million)
  • Table 171. Ayurveda Gastrointestinal Diseases , by Region USD Million (2025-2030)
  • Table 172. Ayurveda Cardiac Disorders , by Region USD Million (2025-2030)
  • Table 173. Ayurveda Respiratory Disorders , by Region USD Million (2025-2030)
  • Table 174. Ayurveda Psychological Disorders , by Region USD Million (2025-2030)
  • Table 175. Ayurveda Movement Disorders , by Region USD Million (2025-2030)
  • Table 176. Ayurveda Others , by Region USD Million (2025-2030)
  • Table 177. Ayurveda: by Treatment(USD Million)
  • Table 178. Ayurveda Vamana , by Region USD Million (2025-2030)
  • Table 179. Ayurveda Virechana , by Region USD Million (2025-2030)
  • Table 180. Ayurveda Nasyam , by Region USD Million (2025-2030)
  • Table 181. Ayurveda Vasthy , by Region USD Million (2025-2030)
  • Table 182. Ayurveda: by Form(USD Million)
  • Table 183. Ayurveda Herbal , by Region USD Million (2025-2030)
  • Table 184. Ayurveda Herbomineral , by Region USD Million (2025-2030)
  • Table 185. Ayurveda Mineral , by Region USD Million (2025-2030)
  • Table 186. Ayurveda: by Distribution Channel(USD Million)
  • Table 187. Ayurveda Online Channel , by Region USD Million (2025-2030)
  • Table 188. Ayurveda Offline Channel , by Region USD Million (2025-2030)
  • Table 189. Ayurveda: by End-user(USD Million)
  • Table 190. Ayurveda Ayurveda Centres , by Region USD Million (2025-2030)
  • Table 191. Ayurveda Hospitals , by Region USD Million (2025-2030)
  • Table 192. Ayurveda Clinics , by Region USD Million (2025-2030)
  • Table 193. Ayurveda Others , by Region USD Million (2025-2030)
  • Table 194. South America Ayurveda, by Country USD Million (2025-2030)
  • Table 195. South America Ayurveda, by Application USD Million (2025-2030)
  • Table 196. South America Ayurveda, by Treatment USD Million (2025-2030)
  • Table 197. South America Ayurveda, by Form USD Million (2025-2030)
  • Table 198. South America Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 199. South America Ayurveda, by End-user USD Million (2025-2030)
  • Table 200. Brazil Ayurveda, by Application USD Million (2025-2030)
  • Table 201. Brazil Ayurveda, by Treatment USD Million (2025-2030)
  • Table 202. Brazil Ayurveda, by Form USD Million (2025-2030)
  • Table 203. Brazil Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 204. Brazil Ayurveda, by End-user USD Million (2025-2030)
  • Table 205. Argentina Ayurveda, by Application USD Million (2025-2030)
  • Table 206. Argentina Ayurveda, by Treatment USD Million (2025-2030)
  • Table 207. Argentina Ayurveda, by Form USD Million (2025-2030)
  • Table 208. Argentina Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 209. Argentina Ayurveda, by End-user USD Million (2025-2030)
  • Table 210. Rest of South America Ayurveda, by Application USD Million (2025-2030)
  • Table 211. Rest of South America Ayurveda, by Treatment USD Million (2025-2030)
  • Table 212. Rest of South America Ayurveda, by Form USD Million (2025-2030)
  • Table 213. Rest of South America Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 214. Rest of South America Ayurveda, by End-user USD Million (2025-2030)
  • Table 215. Asia Pacific Ayurveda, by Country USD Million (2025-2030)
  • Table 216. Asia Pacific Ayurveda, by Application USD Million (2025-2030)
  • Table 217. Asia Pacific Ayurveda, by Treatment USD Million (2025-2030)
  • Table 218. Asia Pacific Ayurveda, by Form USD Million (2025-2030)
  • Table 219. Asia Pacific Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 220. Asia Pacific Ayurveda, by End-user USD Million (2025-2030)
  • Table 221. China Ayurveda, by Application USD Million (2025-2030)
  • Table 222. China Ayurveda, by Treatment USD Million (2025-2030)
  • Table 223. China Ayurveda, by Form USD Million (2025-2030)
  • Table 224. China Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 225. China Ayurveda, by End-user USD Million (2025-2030)
  • Table 226. Japan Ayurveda, by Application USD Million (2025-2030)
  • Table 227. Japan Ayurveda, by Treatment USD Million (2025-2030)
  • Table 228. Japan Ayurveda, by Form USD Million (2025-2030)
  • Table 229. Japan Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 230. Japan Ayurveda, by End-user USD Million (2025-2030)
  • Table 231. India Ayurveda, by Application USD Million (2025-2030)
  • Table 232. India Ayurveda, by Treatment USD Million (2025-2030)
  • Table 233. India Ayurveda, by Form USD Million (2025-2030)
  • Table 234. India Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 235. India Ayurveda, by End-user USD Million (2025-2030)
  • Table 236. South Korea Ayurveda, by Application USD Million (2025-2030)
  • Table 237. South Korea Ayurveda, by Treatment USD Million (2025-2030)
  • Table 238. South Korea Ayurveda, by Form USD Million (2025-2030)
  • Table 239. South Korea Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 240. South Korea Ayurveda, by End-user USD Million (2025-2030)
  • Table 241. Taiwan Ayurveda, by Application USD Million (2025-2030)
  • Table 242. Taiwan Ayurveda, by Treatment USD Million (2025-2030)
  • Table 243. Taiwan Ayurveda, by Form USD Million (2025-2030)
  • Table 244. Taiwan Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 245. Taiwan Ayurveda, by End-user USD Million (2025-2030)
  • Table 246. Australia Ayurveda, by Application USD Million (2025-2030)
  • Table 247. Australia Ayurveda, by Treatment USD Million (2025-2030)
  • Table 248. Australia Ayurveda, by Form USD Million (2025-2030)
  • Table 249. Australia Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 250. Australia Ayurveda, by End-user USD Million (2025-2030)
  • Table 251. Rest of Asia-Pacific Ayurveda, by Application USD Million (2025-2030)
  • Table 252. Rest of Asia-Pacific Ayurveda, by Treatment USD Million (2025-2030)
  • Table 253. Rest of Asia-Pacific Ayurveda, by Form USD Million (2025-2030)
  • Table 254. Rest of Asia-Pacific Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 255. Rest of Asia-Pacific Ayurveda, by End-user USD Million (2025-2030)
  • Table 256. Europe Ayurveda, by Country USD Million (2025-2030)
  • Table 257. Europe Ayurveda, by Application USD Million (2025-2030)
  • Table 258. Europe Ayurveda, by Treatment USD Million (2025-2030)
  • Table 259. Europe Ayurveda, by Form USD Million (2025-2030)
  • Table 260. Europe Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 261. Europe Ayurveda, by End-user USD Million (2025-2030)
  • Table 262. Germany Ayurveda, by Application USD Million (2025-2030)
  • Table 263. Germany Ayurveda, by Treatment USD Million (2025-2030)
  • Table 264. Germany Ayurveda, by Form USD Million (2025-2030)
  • Table 265. Germany Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 266. Germany Ayurveda, by End-user USD Million (2025-2030)
  • Table 267. France Ayurveda, by Application USD Million (2025-2030)
  • Table 268. France Ayurveda, by Treatment USD Million (2025-2030)
  • Table 269. France Ayurveda, by Form USD Million (2025-2030)
  • Table 270. France Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 271. France Ayurveda, by End-user USD Million (2025-2030)
  • Table 272. Italy Ayurveda, by Application USD Million (2025-2030)
  • Table 273. Italy Ayurveda, by Treatment USD Million (2025-2030)
  • Table 274. Italy Ayurveda, by Form USD Million (2025-2030)
  • Table 275. Italy Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 276. Italy Ayurveda, by End-user USD Million (2025-2030)
  • Table 277. United Kingdom Ayurveda, by Application USD Million (2025-2030)
  • Table 278. United Kingdom Ayurveda, by Treatment USD Million (2025-2030)
  • Table 279. United Kingdom Ayurveda, by Form USD Million (2025-2030)
  • Table 280. United Kingdom Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 281. United Kingdom Ayurveda, by End-user USD Million (2025-2030)
  • Table 282. Netherlands Ayurveda, by Application USD Million (2025-2030)
  • Table 283. Netherlands Ayurveda, by Treatment USD Million (2025-2030)
  • Table 284. Netherlands Ayurveda, by Form USD Million (2025-2030)
  • Table 285. Netherlands Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 286. Netherlands Ayurveda, by End-user USD Million (2025-2030)
  • Table 287. Rest of Europe Ayurveda, by Application USD Million (2025-2030)
  • Table 288. Rest of Europe Ayurveda, by Treatment USD Million (2025-2030)
  • Table 289. Rest of Europe Ayurveda, by Form USD Million (2025-2030)
  • Table 290. Rest of Europe Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 291. Rest of Europe Ayurveda, by End-user USD Million (2025-2030)
  • Table 292. MEA Ayurveda, by Country USD Million (2025-2030)
  • Table 293. MEA Ayurveda, by Application USD Million (2025-2030)
  • Table 294. MEA Ayurveda, by Treatment USD Million (2025-2030)
  • Table 295. MEA Ayurveda, by Form USD Million (2025-2030)
  • Table 296. MEA Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 297. MEA Ayurveda, by End-user USD Million (2025-2030)
  • Table 298. Middle East Ayurveda, by Application USD Million (2025-2030)
  • Table 299. Middle East Ayurveda, by Treatment USD Million (2025-2030)
  • Table 300. Middle East Ayurveda, by Form USD Million (2025-2030)
  • Table 301. Middle East Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 302. Middle East Ayurveda, by End-user USD Million (2025-2030)
  • Table 303. Africa Ayurveda, by Application USD Million (2025-2030)
  • Table 304. Africa Ayurveda, by Treatment USD Million (2025-2030)
  • Table 305. Africa Ayurveda, by Form USD Million (2025-2030)
  • Table 306. Africa Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 307. Africa Ayurveda, by End-user USD Million (2025-2030)
  • Table 308. North America Ayurveda, by Country USD Million (2025-2030)
  • Table 309. North America Ayurveda, by Application USD Million (2025-2030)
  • Table 310. North America Ayurveda, by Treatment USD Million (2025-2030)
  • Table 311. North America Ayurveda, by Form USD Million (2025-2030)
  • Table 312. North America Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 313. North America Ayurveda, by End-user USD Million (2025-2030)
  • Table 314. United States Ayurveda, by Application USD Million (2025-2030)
  • Table 315. United States Ayurveda, by Treatment USD Million (2025-2030)
  • Table 316. United States Ayurveda, by Form USD Million (2025-2030)
  • Table 317. United States Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 318. United States Ayurveda, by End-user USD Million (2025-2030)
  • Table 319. Canada Ayurveda, by Application USD Million (2025-2030)
  • Table 320. Canada Ayurveda, by Treatment USD Million (2025-2030)
  • Table 321. Canada Ayurveda, by Form USD Million (2025-2030)
  • Table 322. Canada Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 323. Canada Ayurveda, by End-user USD Million (2025-2030)
  • Table 324. Mexico Ayurveda, by Application USD Million (2025-2030)
  • Table 325. Mexico Ayurveda, by Treatment USD Million (2025-2030)
  • Table 326. Mexico Ayurveda, by Form USD Million (2025-2030)
  • Table 327. Mexico Ayurveda, by Distribution Channel USD Million (2025-2030)
  • Table 328. Mexico Ayurveda, by End-user USD Million (2025-2030)
  • Table 329. Research Programs/Design for This Report
  • Table 330. Key Data Information from Secondary Sources
  • Table 331. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Ayurveda: by Application USD Million (2018-2023)
  • Figure 5. Global Ayurveda: by Treatment USD Million (2018-2023)
  • Figure 6. Global Ayurveda: by Form USD Million (2018-2023)
  • Figure 7. Global Ayurveda: by Distribution Channel USD Million (2018-2023)
  • Figure 8. Global Ayurveda: by End-user USD Million (2018-2023)
  • Figure 9. South America Ayurveda Share (%), by Country
  • Figure 10. Asia Pacific Ayurveda Share (%), by Country
  • Figure 11. Europe Ayurveda Share (%), by Country
  • Figure 12. MEA Ayurveda Share (%), by Country
  • Figure 13. North America Ayurveda Share (%), by Country
  • Figure 14. Global Ayurveda share by Players 2023 (%)
  • Figure 15. Global Ayurveda share by Players (Top 3) 2023(%)
  • Figure 16. Global Ayurveda share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Emami Group (India) Revenue, Net Income and Gross profit
  • Figure 19. Emami Group (India) Revenue: by Geography 2023
  • Figure 20. Vicco Laboratories Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 21. Vicco Laboratories Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 22. Patanjali Ayurved Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 23. Patanjali Ayurved Ltd. (India) Revenue: by Geography 2023
  • Figure 24. Baidyanath Group (India) Revenue, Net Income and Gross profit
  • Figure 25. Baidyanath Group (India) Revenue: by Geography 2023
  • Figure 26. Dabur (India) Revenue, Net Income and Gross profit
  • Figure 27. Dabur (India) Revenue: by Geography 2023
  • Figure 28. Hamdard (Wakf) Laboratories (India) Revenue, Net Income and Gross profit
  • Figure 29. Hamdard (Wakf) Laboratories (India) Revenue: by Geography 2023
  • Figure 30. Charak Pharma (India) Revenue, Net Income and Gross profit
  • Figure 31. Charak Pharma (India) Revenue: by Geography 2023
  • Figure 32. Zandu Pharmaceutical Works Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 33. Zandu Pharmaceutical Works Ltd. (India) Revenue: by Geography 2023
  • Figure 34. Elzac Herbals (India) Revenue, Net Income and Gross profit
  • Figure 35. Elzac Herbals (India) Revenue: by Geography 2023
  • Figure 36. The Himalaya Drug Company (India) Revenue, Net Income and Gross profit
  • Figure 37. The Himalaya Drug Company (India) Revenue: by Geography 2023
  • Figure 38. Global Ayurveda: by Application USD Million (2025-2030)
  • Figure 39. Global Ayurveda: by Treatment USD Million (2025-2030)
  • Figure 40. Global Ayurveda: by Form USD Million (2025-2030)
  • Figure 41. Global Ayurveda: by Distribution Channel USD Million (2025-2030)
  • Figure 42. Global Ayurveda: by End-user USD Million (2025-2030)
  • Figure 43. South America Ayurveda Share (%), by Country
  • Figure 44. Asia Pacific Ayurveda Share (%), by Country
  • Figure 45. Europe Ayurveda Share (%), by Country
  • Figure 46. MEA Ayurveda Share (%), by Country
  • Figure 47. North America Ayurveda Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Emami Group (India)
  • Vicco Laboratories Pvt. Ltd. (India)
  • Patanjali Ayurved Ltd. (India)
  • Baidyanath Group (India)
  • Dabur (India)
  • Hamdard (Wakf) Laboratories (India)
  • Charak Pharma (India)
  • Zandu Pharmaceutical Works Ltd. (India)
  • Elzac Herbals (India)
  • The Himalaya Drug Company (India)
Select User Access Type

Key Highlights of Report


Mar 2024 287 Pages 72 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Ayurveda Market Quantitative research analysis
Global Ayurveda Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Emami Group (India), Vicco Laboratories Pvt. Ltd. (India), Patanjali Ayurved Ltd. (India), Baidyanath Group (India), Dabur (India), Hamdard (Wakf) Laboratories (India), Charak Pharma (India), Zandu Pharmaceutical Works Ltd. (India), Elzac Herbals (India) and The Himalaya Drug Company (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Shifting of Consumers toward Ayurvedic Treatment " is seen as one of major influencing trends for Ayurveda Market during projected period 2023-2030.
The Ayurveda market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Ayurveda Market Report?

Have a Query? Click Here

Other Related Reports

Single Cell Isolation Systems Comprehensive Study by Type (Flow Cytometry Systems, Microfluidic Systems, Laser Microdissection Systems, Others), Application (Drug Discovery, Life Science Research, Ot...
$ 3450
Elderly Care Facilities Comprehensive Study by Type (Pharmaceuticals, Housing and Assistive Devices), Application (Heart Diseases, Cancer, Kidney Diseases, Diabetes, Arthritis, Osteoporosis, Neurolog...
$ 3750
Hematology Therapies Comprehensive Study by Type (Instruments, Consumable), Application (Physiology, Pathology, Etiology, Diagnosis, Treatment, Prognosis), Blood Disorder Type (Hemophilia, Leukemia, ...
$ 3650
Healthcare and Hospital Room Furniture Comprehensive Study by Type (Chairs, Beds, Tables, Others), Application (Physicians Furniture, Patient Furniture, Staff Furniture), Department (Day Care, Emerge...
$ 3450
Coronavirus Diagnostics Comprehensive Study by Type (Molecular, Serology, Antigen-Based), Product Used (Instruments, Reagents & Kits), Infection Type (HCoV-229E, HCoV-OC43, SARS-CoV, HKU1-CoV, MERS-C...
$ 3750
Freestanding Emergency Department Comprehensive Study by Type (Ophthalmology, Internal Medicine, Otolaryngology, Others), End users (Hospital, Clinic, Others), Ownership (Off-Campus Emergency Departm...
$ 3650